Your shopping cart is currently empty

Survodutide TFA (BI 456906 TFA) is a selective and efficient dual agonist of the glucagon receptor/GLP-1 receptor (GCGR/GLP-1R), a peptide compound used in obesity research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $93 | In Stock | In Stock | |
| 5 mg | $230 | In Stock | In Stock | |
| 10 mg | $345 | In Stock | In Stock | |
| 25 mg | $660 | In Stock | In Stock | |
| 50 mg | $917 | - | In Stock | |
| 100 mg | $1,210 | - | In Stock |
| Description | Survodutide TFA (BI 456906 TFA) is a selective and efficient dual agonist of the glucagon receptor/GLP-1 receptor (GCGR/GLP-1R), a peptide compound used in obesity research. |
| Synonyms | BI-456909 TFA, BI456909 TFA, BI456906 TFA, BI 456906 TFA |
| Molecular Weight | 4231.62 (free base) |
| Formula | C192H289N47O61.xC2HF3OC2 |
| Sequence | H-{1-amino-1-cyclobutanecarboxylic acid}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Arg-Ala-Ala-Lys-Asp-Phe-Ile-Lys-{GGSGSG-γE-C18 di-acid)}-Trp-Leu-Glu-Ser-Ala |
| Sequence Short | {1-amino-1-cyclobutanecarboxylic acid}-QGTFTSDYSKYLDERAAKDFIK-{GGSGSG-γE-C18 di-acid)}-WLESA |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: 80 mg/mL, Sonication is recommended. DMSO: 80 mg/mL, Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.